Diagnosis and treatment progress of nephron-sparing surgery in the treatment of upstaging pT3a renal carcinoma
10.3969/j.issn.1009-8291.2023.08.017
- VernacularTitle:保留肾单位手术在术后升期为pT3a期肾癌的诊治进展
- Author:
Keruo WANG
1
;
Yaru LIU
2
;
Gang LI
1
Author Information
1. Tianjin Institute of Urology, Department of Urology, The Second Hospital of Tianjin Medical Univer-sity, Tianjin 300211
2. Emergency Department, The Second Hospital of Tianjin Medical University, Tianjin 300211, China
- Publication Type:Journal Article
- Keywords:
nephron-sparing surgery;
renal cell carcinoma;
risk factors;
pathological staging;
imaging;
radical nephrectomy
- From:
Journal of Modern Urology
2023;28(8):725-728
- CountryChina
- Language:Chinese
-
Abstract:
Nephron-sparing surgery (NSS) is the standard treatment method for T1 and some T2 stage renal cell carcinoma (RCC), but it is not recommended for T3 stage RCC. Due to the limited sensitivity and specificity of preoperative imaging, some cT1/2 upstaging to pT3a RCC patients also receive NSS. The efficacy of NSS versus radical nephrectomy for upstaging to T3a RCC remains highly controversial. This article summarizes the preoperative imaging diagnostic criteria of T3a RCC and risk factors of upstaging to pT3a, and compares the efficacy and prognosis between NSS and radical nephrectomy for upstaging to pT3a RCC.
